Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Downing

Showing results (431-440 of 537) with videos related to

Pageof 54
Sort By:
British Journal of Haematology|August 29, 2014
Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapySeth E Karol, Elaine Coustan-Smith, Xueyuan Cao, et al.
Leukemia|June 8, 2011
IDH1 and IDH2 mutations in pediatric acute leukemiaA K Andersson, D W Miller, J A Lynch, et al.
Blood|October 11, 2012
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterationsJennifer Edelmann, Karlheinz Holzmann, Florian Miller, et al.
Oncogene|May 10, 2011
Shared acquired genomic changes in zebrafish and human T-ALLL A Rudner, K H Brown, K P Dobrinski, et al.
Nature Communications|November 18, 2017
An unexpected protein interaction promotes drug resistance in leukemiaAaron Pitre, Yubin Ge, Wenwei Lin, et al.
JCI Insight|July 27, 2018
Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomesJasmine C Wong, Victoria Bryant, Tamara Lamprecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemiaIna Radtke, Charles G Mullighan, Masami Ishii, et al.
Blood|September 1, 2011
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Alex Kentsis, Takaomi Sanda, et al.
Blood|July 1, 2004
Gene expression profiling of pediatric acute myelogenous leukemiaMary E Ross, Rami Mahfouz, Mihaela Onciu, et al.
The Lancet. Oncology|May 11, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialJeffrey E Rubnitz, Hiroto Inaba, Gary Dahl, et al.
Pageof 54

Showing results (431-440 of 537) with videos related to

Sort By:
Pageof 54
British Journal of Haematology|August 29, 2014
Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapySeth E Karol, Elaine Coustan-Smith, Xueyuan Cao, et al.
Leukemia|June 8, 2011
IDH1 and IDH2 mutations in pediatric acute leukemiaA K Andersson, D W Miller, J A Lynch, et al.
Blood|October 11, 2012
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterationsJennifer Edelmann, Karlheinz Holzmann, Florian Miller, et al.
Oncogene|May 10, 2011
Shared acquired genomic changes in zebrafish and human T-ALLL A Rudner, K H Brown, K P Dobrinski, et al.
Nature Communications|November 18, 2017
An unexpected protein interaction promotes drug resistance in leukemiaAaron Pitre, Yubin Ge, Wenwei Lin, et al.
JCI Insight|July 27, 2018
Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomesJasmine C Wong, Victoria Bryant, Tamara Lamprecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemiaIna Radtke, Charles G Mullighan, Masami Ishii, et al.
Blood|September 1, 2011
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Alex Kentsis, Takaomi Sanda, et al.
Blood|July 1, 2004
Gene expression profiling of pediatric acute myelogenous leukemiaMary E Ross, Rami Mahfouz, Mihaela Onciu, et al.
The Lancet. Oncology|May 11, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialJeffrey E Rubnitz, Hiroto Inaba, Gary Dahl, et al.
Pageof 54